Nash, R. A., McSweeney, P. A., Crofford, L. J., McDonagh, K. T., Sullivan, K. M., Maureen, M., … Furst, D. E. (2006). 5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc). In ARTHRITIS AND RHEUMATISM (Vol. 54, pp. S315–S315). Washington, DC: WILEY-LISS.

Nash, Richard A., Peter A. McSweeney, Leslie J. Crofford, Kevin T. McDonagh, Keith M. Sullivan, Mayes Maureen, J Lee Nelson, et al. “5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc).” In ARTHRITIS AND RHEUMATISM, 54:S315–S315. WILEY-LISS, 2006.

Nash RA, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Maureen M, et al. 5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc). In: ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2006. p. S315–S315.

Nash, Richard A., et al. “5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc).” ARTHRITIS AND RHEUMATISM, vol. 54, no. 9, WILEY-LISS, 2006, pp. S315–S315.

Nash RA, McSweeney PA, Crofford LJ, McDonagh KT, Sullivan KM, Maureen M, Nelson JL, Gooley T, Holmberg L, Shulman H, Wener M, McLaughlin B, Henstorf G, Molitor J, Seibold JR, Furst DE. 5-year follow-up of high-dose immunosuppressive therapy (HDIT) for systemic sclerosis (SSc). ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2006. p. S315–S315.